Characteristic | Low expression of TNFAIP2 (n = 75) | High expression of TNFAIP2 (n = 76) | P value |
---|---|---|---|
Gender (male), n (%) | 41 (27.2%) | 42 (27.8%) | 1.000 |
Age, median (IQR) | 51 (35.5, 61.5) | 62 (48, 70.25) | < 0.001 |
WBC count(× 109/L), median (IQR) | 13 (3, 39.5) | 27 (6.75, 69) | 0.018 |
Cytogenetic risk, n (%) | |||
 Favorable | 21 (14.1%) | 10 (6.7%) | 0.024 |
 Intermediate | 38 (25.5%) | 44 (29.5%) | 0.369 |
 Poor | 15 (10.1%) | 21 (14.1%) | 0.27 |
FAB classifications, n (%) | |||
 M0 | 9 (6%) | 6 (4%) | 0.384 |
 M1 | 16 (10.7%) | 19 (12.7%) | 0.625 |
 M2 | 26 (17.3%) | 12 (8%) | 0.006 |
 M3 | 14 (9.3%) | 1 (0.7%) | 0.001 |
 M4 | 4 (2.7%) | 25 (16.7%) | < 0.001 |
 M5 | 3 (2%) | 12 (8%) | 0.034 |
 M6 | 1 (0.7%) | 1 (0.7%) | 1.000 |
 M7 | 1 (0.7%) | 0 (0%) | 0.493 |
Cytogenetics, n (%) | |||
 Normal | 35 (25.9%) | 34 (25.2%) | 0.718 |
  + 8 | 3 (2.2%) | 5 (3.7%) | 0.620 |
 del(5) | 1 (0.7%) | 0 (0%) | 1.000 |
 del(7) | 1 (0.7%) | 5 (3.7%) | 0.172 |
 inv.(16) | 1 (0.7%) | 7 (5.2%) | 0.051 |
 t(15;17) | 11 (8.1%) | 0 (0%) | 0.001 |
 t(8;21) | 7 (5.2%) | 0 (0%) | 0.014 |
 t(9;11) | 0 (0%) | 1 (0.7%) | 0.478 |
 Complex | 12 (8.9%) | 12 (8.9%) | 0.809 |
OS event, n (%) | Â | Â | 0.023 |
 Alive | 34 (22.5%) | 20 (13.2%) |  |
 Dead | 41 (27.2%) | 56 (37.1%) |  |